|
Volumn 106, Issue 10, 2002, Pages 1180-1182
|
Blunderbuss to Mickey Mouse: The evolution of antiarrhythmic targets
a |
Author keywords
Antiarrhythmia agents; Drugs; Editorials; Hypertrophy
|
Indexed keywords
AJMALINE;
AMIODARONE;
ANTIARRHYTHMIC AGENT;
AZIMILIDE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ION;
DISOPYRAMIDE;
DOFETILIDE;
ENCAINIDE;
FLECAINIDE;
IBUTILIDE;
ISOPRENALINE;
LIDOCAINE;
MORACIZINE;
PHENYTOIN;
PROCAINAMIDE;
PROCAINE;
PROPRANOLOL;
PROTEIN KINASE (CALCIUM,CALMODULIN);
QUINIDINE;
SOTALOL;
ANIMAL MODEL;
ANTIARRHYTHMIC ACTIVITY;
ARRHYTHMOGENESIS;
CLINICAL TRIAL;
EDITORIAL;
ELECTROCARDIOGRAM;
ENZYME INHIBITION;
HEART ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HEART VENTRICLE HYPERTROPHY;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
LONG QT SYNDROME;
NONHUMAN;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANIMALS;
ANTI-ARRHYTHMIA AGENTS;
ARRHYTHMIA;
CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE;
CARDIOMEGALY;
DRUG DELIVERY SYSTEMS;
ENZYME INHIBITORS;
HUMANS;
MICE;
|
EID: 0037015290
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000031166.57095.04 Document Type: Editorial |
Times cited : (3)
|
References (27)
|